Florence Dalenc

ScholarGPS® ID: 35249858433380

Affiliation

Claudius Regaud Institute, France

Affiliation History

Field

Medicine

Discipline

Oncology

Top Specialties

Metrics Summary

Publication Count

286

Predicted Citations

8,931

Predicted h-index

Ranking

Publications and Citation History

Publications based on Top Specialties

Types of Publication

Publications
Books
Patents
NIH/NSF

Add Delete
Identification of non-adherence to adjuvant letrozole using a population pharmacokinetics approach in hormone receptor-positive breast cancer patients (journal article) Puszkiel, Alicja \| Dalenc, Florence \| Tafzi, Naïma \| Marquet, Pierre \| Debled, Marc \| Jacot, William \| Venat-Bouvet, Laurence \| Ferrer, Catherine \| Levasseur, Nadia \| Paulon, Rodolphe \| ... \| White-Koning, Melanie European Journal of Pharmaceutical Sciences, volume 199 (2024). 10.1016/j.ejps.2024.106809 Cite \| Source
Clinical utility of ctDNA as a tool to detect triple-negative breast cancer relapses: The CUPCAKE trial. (journal article) Bidard, Francois Clement \| Berger, Frederique \| Arnedos, Monica \| Mouret-Reynier, Marie-Ange \| Tredan, Olivier \| Sabatier, Renaud \| Jacot, William \| Massard, Vincent \| De La Motte Rouge, Thibault \| Gligorov, Joseph \| ... \| Kiavue, Nicolas Journal of Clinical Oncology, volume 42, issue 16_suppl, pages TPS1139-TPS1139 (2024). 10.1200/JCO.2024.42.16_suppl.TPS1139 Cite \| Source
Combination of predicted sensitivity to endocrine therapy (SET2,3 index) and the Recurrence Score in node-positive breast cancer: Independent validation in the PACS-01 trial. (journal article) Penault-Llorca, Frederique Madeleine \| Lusque, Amelie \| Filleron, Thomas \| Tran, Kevin \| Du, Lili \| Baehner, Frederick \| Dalenc, Florence \| Lacroix-Triki, Magali \| Bachelot, Thomas \| Andre, Fabrice \| ... \| Symmans, W. Fraser Fraser Journal of Clinical Oncology, volume 42, issue 16_suppl, pages 565-565 (2024). 10.1200/JCO.2024.42.16_suppl.565 Cite \| Source
Health-related quality of life with sacituzumab govitecan in HR+/HER2− metastatic breast cancer in the phase III TROPiCS-02 trial (journal article) Rugo, Hope S \| Schmid, Peter \| Tolaney, Sara M \| Dalenc, Florence \| Marmé, Frederik \| Shi, Ling \| Verret, Wendy \| Shah, Anuj \| Gharaibeh, Mahdi \| Bardia, Aditya \| Cortes, Javier The Oncologist (2024). 10.1093/oncolo/oyae088 Cite \| Source
183MO Capivasertib and fulvestrant (F) for patients (pts) with aromatase inhibitor (AI)-resistant HR+/HER2- advanced breast cancer (ABC): Second progression-free survival (PFS2) and time to first subsequent chemotherapy (TFSC) in the CAPItello-291 trial (journal article) Rugo, H.S. \| Oliveira, M. \| Howell, S.J. \| Dalenc, F. \| Cortés, J. \| Moreno, H.L. Gomez \| Hu, X. \| Jhaveri, K. \| Loibl, S. \| Murillo, S. Morales \| ... \| Turner, N. ESMO Open, volume 9 (2024). 10.1016/j.esmoop.2024.103205 Cite \| Source
4MO Neoadjuvant letrozole and palbociclib versus chemotherapy in the NeoPAL study: A translational analysis (journal article) Cottu, P.H. \| Kieffer, Y. \| Lemonnier, J. \| D'Hondt, V. \| Duhoux, F.P. \| Callens, C. \| Gentien, D. \| Desmoulins, I. \| Mouret-Reynier, M-A. \| Levy, C. \| ... \| Vincent-Salomon, A. ESMO Open, volume 9 (2024). 10.1016/j.esmoop.2024.103014 Cite \| Source
p4EBP1 staining predicts outcome in ER-positive endocrine-resistant metastatic breast cancer patients treated with everolimus and exemestane (journal article) Vanacker, Hélène \| Treilleux, Isabelle \| Schiffler, Camille \| Bieche, Ivan \| Campone, Mario \| Patsouris, Anne \| Arnedos, Monica \| Cottu, Paul H. \| Jacquin, Jean-Philippe \| Dalenc, Florence \| ... \| Bachelot, Thomas British Journal of Cancer, volume 130, issue 4, pages 613-619 (2024). 10.1038/s41416-023-02549-8 Cite \| Source
PO143 MODELING AN ANNOUNCEMENT PATHWAY FOR PATIENTS ENTERING METASTATIC DISEASE CLINICAL ISSUES: SUPPORTIVE AND PALLIATIVE CARE (journal article) Mouret-Reynier, Marie-Ange \| Dalenc, Florence \| Guiu, Severine \| Quenel-Tueux, Nathalie The Breast, volume 71 (2023). 10.1016/S0960-9776(23)00707-5 Cite \| Source
Overall survival with sacituzumab govitecan in hormone receptor-positive and human epidermal growth factor receptor 2-negative metastatic breast cancer (TROPiCS-02): a randomised, open-label, multicentre, phase 3 trial (journal article) Rugo, Hope S \| Bardia, Aditya \| Marmé, Frederik \| Cortés, Javier \| Schmid, Peter \| Loirat, Delphine \| Trédan, Olivier \| Ciruelos, Eva \| Dalenc, Florence \| Gómez Pardo, Patricia \| ... \| Tolaney, Sara M The Lancet, volume 402, issue 10411, pages 1423-1433 (2023). 10.1016/S0140-6736(23)01245-X Cited by (75) \| Cite \| Source
Chimiothérapie néoadjuvante : pour qui et comment ? (journal article) Dalenc, Florence \| Poumeaud, François Innovations & Thérapeutiques en Oncologie, volume 9, issue S1, pages 23-27 (2023). 10.1684/ito.2023.390 Cite \| Source
Compliance to genomic test recommendations to guide adjuvant chemotherapy decision‐making in the case of hormone receptor‐positive, human epidermal growth factor receptor 2‐negative breast cancer, in real‐life settings (journal article) Hequet, D. \| Hajjaji, N. \| Charafe‐Jauffret, E. \| Boucrauta, A. \| Dalenc, F. \| Nicolai, V. \| Lopez, J. \| Tredan, O. \| Deluche, E. \| Fermeaux, V. \| ... \| Rouzier, R. Cancer Medicine, volume 12, issue 16, pages 16889-16895 (2023). 10.1002/cam4.6315 Cite \| Source
The beneficial effects of tamoxifen on arteries: A key player for cardiovascular health of breast cancer patient (journal article) Davezac, Morgane \| Meneur, Cecile \| Buscato, Melissa \| Zahreddine, Rana \| Arnal, Jean-François \| Dalenc, Florence \| Lenfant, Françoise \| Fontaine, Coralie Biochemical Pharmacology, volume 214 (2023). 10.1016/j.bcp.2023.115677 Cited by (1) \| Cite \| Source
Investigating the clinical impact of dose‐banding for weekly paclitaxel in patients with breast cancer: A retrospective and monocentric study (journal article) Puisset, Florent \| Le Louedec, Félicien \| Dalenc, Florence \| Verguet, Lorène \| De Maio, Eleonora \| Lacaze, Jean Louis \| Montastruc, Marion \| Ung, Mony \| Vinson, Camille \| Perriat, Sophie \| ... \| Koning, Mélanie White British Journal of Clinical Pharmacology, volume 89, issue 7, pages 2283-2294 (2023). 10.1111/bcp.15702 Cite \| Source
Training and validation of a model predicting clusters of long-term cancer-related behavioral symptoms (CRBS) after breast cancer (BC). (journal article) Pagliuca, Martina \| Havas, Julie \| Lerebours, Florence \| Rigal, Olivier \| Petit, Thierry \| Giacchetti, Sylvie \| Dalenc, Florence \| Wassermann, Johanna \| Arsene, Olivier \| Martin, Anne-Laure \| ... \| Di Meglio, Antonio Journal of Clinical Oncology, volume 41, issue 16_suppl, pages 12087-12087 (2023). 10.1200/JCO.2023.41.16_suppl.12087 Cite \| Source
Prognostic factors in hormone receptor positive oligometastatic breast cancer. (journal article) Jean Louis, Lacaze \| Cabarrou, Bastien \| Glemarec, Gauthier \| Brac de la Perrière, Clémence \| Cassou Mounat, Thibaut \| Chira, Ciprian \| De Maio, Eleonora \| Jouve, Eva \| Massabeau, Carole \| Nicolai, Vincent \| ... \| Dalenc, Florence Journal of Clinical Oncology, volume 41, issue 16_suppl, pages 1058-1058 (2023). 10.1200/JCO.2023.41.16_suppl.1058 Cite \| Source
Final overall survival (OS) analysis from the phase 3 TROPiCS-02 study of sacituzumab govitecan (SG) in patients (pts) with hormone receptor–positive/HER2-negative (HR+/HER2–) metastatic breast cancer (mBC). (journal article) Tolaney, Sara M. \| Bardia, Aditya \| Marmé, Frederik \| Cortés, Javier \| Schmid, Peter \| Loirat, Delphine \| Tredan, Olivier \| Ciruelos, Eva M \| Dalenc, Florence \| Gómez Pardo, Patricia \| ... \| Rugo, Hope S. Journal of Clinical Oncology, volume 41, issue 16_suppl, pages 1003-1003 (2023). 10.1200/JCO.2023.41.16_suppl.1003 Cited by (15) \| Cite \| Source
Erratum to ‘Systemic treatment with or without ablative therapies in oligometastatic breast cancer: A single institution analysis of patient outcomes’ [The Breast (2023) 102–109] (journal article) Glemarec, Gauthier \| Lacaze, Jean-Louis \| Cabarrou, Bastien \| Aziza, Richard \| Jouve, Eva \| Zerdoud, Slimane \| De Maio, Eleonora \| Massabeau, Carole \| Loo, Maxime \| Esteyrie, Vincent \| ... \| Chira, Ciprian The Breast, volume 69 (2023). 10.1016/j.breast.2023.03.011 Cite \| Source
Traitement de première ligne et survie en vie réelle des femmes âgées atteintes d'un cancer du sein métastatique RH+/HER2- par rapport aux femmes plus jeunes : résultats de l’étude observationnelle et nationale ESME (journal article) Bouteiller, F. \| Courtinard, C. \| Gourgou, S. \| Galvin, A. \| Dalenc, F. \| Mailliez, A. \| Bringuier, M. \| Delaloge, S. \| Bellera, C. Revue d'Épidémiologie et de Santé Publique, volume 71 (2023). 10.1016/j.respe.2023.101788 Cite \| Source
131P Efficacy of neoadjuvant letrozole and palbociclib in HER2-low vs HER2 zero luminal breast cancer: An analysis of the Unicancer Neopal phase II study (journal article) Frenel, J.S. \| Vincent-Salomon, A. \| Lemonnier, J. \| D'Hondt, V. \| Desmoulins, I. \| Heudel, P.E. \| Duhoux, F.P. \| Emile, G. \| Mouret Reynier, M.A. \| Dalenc, F. \| ... \| Cottu, P.H. ESMO Open, volume 8, issue 1, pages 101470- (2023). 10.1016/j.esmoop.2023.101470 Cite \| Source
193MO Development of a deep learning model using a large real-world database to predict overall survival in patients with metastatic breast cancer (MBC) (journal article) Vuduc, L. \| Jacot, W. \| Frenel, J-S. \| Brain, E.G.C. \| Dieras, V.C. \| Bachelot, T. \| Mailliez, A. \| Dalenc, F. \| Cottu, P.H. \| Arnedos, M. \| ... \| Delaloge, S. ESMO Open, volume 8, issue 1, pages 101382- (2023). 10.1016/j.esmoop.2023.101382 Cite \| Source